⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5614202 | 1.00 | — | — | |
| SCHEMBL5613975 | 1.00 | — | — | |
| Formic Acid SCHEMBL27742985 | 0.86 | TRPM8 (0.47) | — | |
| SCHEMBL17274587 | 0.83 | TRPA1 (0.38) | — | |
| SCHEMBL22803205 | 0.83 | TRPA1 (0.38) | — | |
| SCHEMBL17274588 | 0.83 | TRPA1 (0.38) | — | |
| SCHEMBL598214 | 0.83 | TRPA1 (0.38) | — | |
| SCHEMBL17274585 | 0.83 | TRPA1 (0.38) | — | |
| SCHEMBL17274586 | 0.83 | TRPA1 (0.38) | — | |
| SCHEMBL24894585 | 0.83 | TRPA1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2829555-B1 | METHOD FOR PRODUCING OLEFIN POLYMER | MITSUI CHEMICALS INC (JP) | 2018-05-16 | — | — | EP | claimed |
| CN-104203993-B | Process for producing olefin polymer | 三井化学株式会社 | 2016-06-15 | — | — | CN | claimed |
| US-9315602-B2 | Method for producing olefin polymer | MITSUI CHEMICALS, INC. (JP) | 2016-04-19 | — | — | US | claimed |
| JP-2007507434-A | — | — | 2007-03-29 | — | — | JP | claimed |
| EP-1668102-A1 | 3-ISOPROPYL-1-METHYLCYCLOPENTYL DERIVATIVES AND THEIR USE IN FRAGRANCE APPLICATIONS | Givaudan SA (CH) | 2006-06-14 | — | — | EP | claimed |
| WO-2005030914-A1 | 3-ISOPROPYL-1-METHYLCYCLOPENTYL DERIVATIVES AND THEIR USE IN FRAGRANCE APPLICATIONS | GIVAUDAN SA (CH) | 2005-04-07 | — | — | WO | claimed |
| WO-2020114934-A1 | HERBICIDE COMPOSITIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-06-11 | — | — | WO | disclosed |
| EP-3082877-B1 | CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF | NOVARTIS AG (CH) | 2019-08-28 | — | — | EP | disclosed |
| EP-2829555-B1 | METHOD FOR PRODUCING OLEFIN POLYMER | MITSUI CHEMICALS INC (JP) | 2018-05-16 | — | — | EP | disclosed |
| US-9616037-B2 | Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use | PIMCO 2664 LIMITED (GB) | 2017-04-11 | — | — | US | disclosed |
| US-9315602-B2 | Method for producing olefin polymer | MITSUI CHEMICALS, INC. (JP) | 2016-04-19 | — | — | US | disclosed |
| CN-102830211-B | A kind of pollution entering the water meet an urgent need pollutant overall target screening method | JINAN RESEARCH INSTITUTE OF ENVIRONMENTAL PROTECTION (CN) | 2015-08-12 | — | — | CN | disclosed |
| US-20150045523-A1 | METHOD FOR PRODUCING OLEFIN POLYMER | MITSUI CHEMICALS, INC. (JP) | 2015-02-12 | — | — | US | disclosed |
| EP-1668102-A1 | 3-ISOPROPYL-1-METHYLCYCLOPENTYL DERIVATIVES AND THEIR USE IN FRAGRANCE APPLICATIONS | Givaudan SA (CH) | 2006-06-14 | — | — | EP | disclosed |
| EP-1537099-A1 | PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 | CHIRON CORPORATION (US) | 2005-06-08 | — | — | EP | disclosed |
| WO-2005030914-A1 | 3-ISOPROPYL-1-METHYLCYCLOPENTYL DERIVATIVES AND THEIR USE IN FRAGRANCE APPLICATIONS | GIVAUDAN SA (CH) | 2005-04-07 | — | — | WO | disclosed |
| WO-2005030915-A1 | 3-ISOPROPYL-1-METHYLCYCLOPENTYL DERIVATIVES AND THEIR USE IN FRAGRANCE APPLICATIONS | GIVAUDAN SA (CH) | 2005-04-07 | — | — | WO | disclosed |
| WO-2005030915-A1 | 3-ISOPROPYL-1-METHYLCYCLOPENTYL DERIVATIVES AND THEIR USE IN FRAGRANCE APPLICATIONS | GIVAUDAN SA (CH) | 2005-04-07 | — | — | WO | disclosed |
| US-20040077707-A1 | Pyrrole based inhibitors of glycogen synthase kinase 3 | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2004-04-22 | — | — | US | disclosed |
| WO-2004018455-A1 | PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 | CHIRON CORPORATION (US) | 2004-03-04 | — | — | WO | disclosed |